HLA-C and psoriatic arthritis: These correlations were not driven by any clinical covariate previously associated with response to adalimumab such as age, gender, ethnicity, smoking, weight, psoriatic arthritis, being biologic naive, the baseline PASI or the presence of the HLA-C*06:02 allele8,10 (Supplementary Data 7).